CD46 signaling in T cells: Linking pathogens with polarity

FEBS Letters

Volumn 584, Issue 24, 2010, Pages 4838-4844

  Hawkins, Edwin D ^a   Oliaro, Jane ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

CD46; Pathogens; Polarity; T cells

Indexed keywords

CELL PROTEIN; MEMBRANE COFACTOR PROTEIN; PROTEIN DLG; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; BACTERIAL INFECTION; CELL DIVISION; CELL FATE; CELL POLARITY; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INFECTION; LIPID RAFT; MALIGNANT NEOPLASTIC DISEASE; MEASLES; MEASLES VIRUS; MOLECULAR INTERACTION; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD46; CELL POLARITY; HUMANS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

BACTERIA (MICROORGANISMS);

EID: 78649876882     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.09.003     Document Type: Review

References (64)

1. Seya T., Nomura Y., Murakami N.A., Begum N.A., Matsumoto M., Nagasawa S. CD46 (membrane cofactor protein of complement, measles virus receptor): structural and functional divergence among species. Int. J. Mol. Med. 1998, 1:809-816.
2. Molina H. The murine complement regulator Crry: new insights into the immunobiology of complement regulation. Cell. Mol. Life Sci. 2002, 59:220-229.
3. Purcell D.F., Russell S.M., Deacon N.J., Brown M.A., Hooker D.J., McKenzie I.F. Alternatively spliced RNAs encode several isoforms of CD46 (MCP), a regulator of complement activation. Immunogenetics 1991, 33:335-344.
4. Longhi M.P., Harris C.L., Morgan B.P., Gallimore A. Holding T cells in check - a new role for complement regulators?. Trends Immunol. 2006, 27:102-108.
5. Berger S.P., Daha M.R. Complement in glomerular injury. Semin. Immunopathol. 2007, 29:375-384.
6. Cattaneo R. Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens' magnet. J. Virol. 2004, 78:4385-4388.
7. Giannakis E., et al. Identification of the streptococcal M protein binding site on membrane cofactor protein (CD46). J. Immunol. 2002, 168:4585-4592.
8. Krummel M.F., Macara I. Maintenance and modulation of T cell polarity. Nat. Immunol. 2006, 7:1143-1149.
9. Dustin M.L. Hunter to gatherer and back: immunological synapses and kinapses as variations on the theme of amoeboid locomotion. Annu. Rev. Cell Dev. Biol. 2008, 24:577-596.
10. Astier A., Trescol-Biemont M.C., Azocar O., Lamouille B., Rabourdin-Combe C. Cutting edge: CD46, a new costimulatory molecule for T cells, that induces p120CBL and LAT phosphorylation. J. Immunol. 2000, 164:6091-6095.
11. Wang G., Liszewski M.K., Chan A.C., Atkinson J.P. Membrane cofactor protein (MCP; CD46): isoform-specific tyrosine phosphorylation. J. Immunol. 2000, 164:1839-1846.
12. Sanchez A., Feito M.J., Rojo J.M. CD46-mediated costimulation induces a Th1-biased response and enhances early TCR/CD3 signaling in human CD4+ T lymphocytes. Eur. J. Immunol. 2004, 34:2439-2448.
13. Zaffran Y., Destaing O., Roux A., Ory S., Nheu T., Jurdic P., Rabourdin-Combe C., Astier A.L. CD46/CD3 costimulation induces morphological changes of human T cells and activation of Vav, Rac, and extracellular signal-regulated kinase mitogen-activated protein kinase. J. Immunol. 2001, 167:6780-6785.
14. Oliaro J., Pasam A., Waterhouse N.J., Browne K.A., Ludford-Menting M.J., Trapani J.A., Russell S.M. Ligation of the cell surface receptor, CD46, alters T cell polarity and response to antigen presentation. Proc. Natl. Acad. Sci. USA 2006, 103:18685-18690.
15. Russell S. How polarity shapes the destiny of T cells. J. Cell Sci. 2008, 121:131-136.
16. Ludford-Menting M.J., Thomas S.J., Crimeen B., Harris L.J., Loveland B.E., Bills M., Ellis S., Russell S.M. A functional interaction between CD46 and DLG4: a role for DLG4 in epithelial polarization. J. Biol. Chem. 2002, 277:4477-4484.
17. Humbert P.O., Dow L.E., Russell S.M. The Scribble and Par complexes in polarity and migration: friends or foes?. Trends Cell Biol. 2006, 16:622-630.
18. Lasserre R., et al. Ezrin tunes T-cell activation by controlling Dlg1 and microtubule positioning at the immunological synapse. EMBO J. 2010, 29:2301-2314.
19. Faure S., Salazar-Fontana L.I., Semichon M., Tybulewicz V.L., Bismuth G., Trautmann A., Germain R.N., Delon J. ERM proteins regulate cytoskeleton relaxation promoting T cell-APC conjugation. Nat. Immunol. 2004, 5:272-279.
20. Ludford-Menting M.J., et al. A network of PDZ-containing proteins regulates T cell polarity and morphology during migration and immunological synapse formation. Immunity 2005, 22:737-748.
21. Etienne-Manneville S., Manneville J.B., Nicholls S., Ferenczi M.A., Hall A. Cdc42 and Par6-PKCzeta regulate the spatially localized association of Dlg1 and APC to control cell polarization. J. Cell Biol. 2005, 170:895-901.
22. Funke L., Dakoji S., Bredt D.S. Membrane-associated guanylate kinases regulate adhesion and plasticity at cell junctions. Annu. Rev. Biochem. 2005, 74:219-245.
23. Xavier R., et al. Discs large (Dlg1) complexes in lymphocyte activation. J. Cell Biol. 2004, 166:173-178.
24. Ralston K.J., et al. The LFA-1-associated molecule PTA-1 (CD226) on T cells forms a dynamic molecular complex with protein 4.1G and human discs large. J. Biol. Chem. 2004, 279:33816-33828.
25. Round J.L., Humphries L.A., Tomassian T., Mittelstadt P., Zhang M., Miceli M.C. Scaffold protein Dlgh1 coordinates alternative p38 kinase activation, directing T cell receptor signals toward NFAT but not NF-kappaB transcription factors. Nat. Immunol. 2007, 8:154-161.
26. Round J.L., Tomassian T., Zhang M., Patel V., Schoenberger S.P., Miceli M.C. Dlgh1 coordinates actin polymerization, synaptic T cell receptor and lipid raft aggregation, and effector function in T cells. J. Exp. Med. 2005, 201:419-430.
27. Marie J.C., Astier A.L., Rivailler P., Rabourdin-Combe C., Wild T.F., Horvat B. Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell induced inflammation. Nat. Immunol. 2002, 3:659-666.
28. Harder T., Sangani D. Plasma membrane rafts engaged in T cell signalling: new developments in an old concept. Cell Commun. Signal 2009, 7:21.
29. Russell S., Oliaro J. Compartmentalization in T-cell signalling: membrane microdomains and polarity orchestrate signalling and morphology. Immunol. Cell Biol. 2006, 84:107-113.
30. Gaus K., Chklovskaia E., Jessup B., Jessup W., Harder T. Condensation of the plasma membrane at the site of T lymphocyte activation. J. Cell Biol. 2005, 171:121-131.
31. Rentero C., et al. Functional implications of plasma membrane condensation for T cell activation. PLoS ONE 2008, 3:e2262.
32. Tang H., Kawabata A., Takemoto M., Yamanishi K., Mori Y. Human herpesvirus-6 infection induces the reorganization of membrane microdomains in target cells, which are required for virus entry. Virology 2008, 378:265-271.
33. Hanada T., Lin L., Tibaldi E.V., Reinherz E.L., Chishti A.H. GAKIN, a novel kinesin-like protein associates with the human homologue of the Drosophila discs large tumor suppressor in T lymphocytes. J. Biol. Chem. 2000, 275:28774-28784.
34. Kaizuka Y., Douglass A.D., Vardhana S., Dustin M.L., Vale R.D. The coreceptor CD2 uses plasma membrane microdomains to transduce signals in T cells. J. Cell Biol. 2009, 185:521-534.
35. Kemper C., Chan A.C., Green J.M., Brett K.A., Murphy K.M., Atkinson J.P. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003, 421:388-392.
36. Oliaro J., et al. Asymmetric cell division of T cells upon antigen presentation uses multiple conserved mechanisms. J Immunol 2010, 185:367-375.
37. Chang J.T., et al. Asymmetric T lymphocyte division in the initiation of adaptive immune responses. Science 2007, 315:1687-1691.
38. Knoblich J.A. Mechanisms of asymmetric stem cell division. Cell 2008, 132:583-597.
39. Global reductions in measles mortality 2000-2008 and the risk of measles resurgence. Weekly Epidemiological Report 2009, 84:505-516. WHO.
40. Schneider-Schaulies J., Schneider-Schaulies S. Receptor interactions, tropism, and mechanisms involved in morbillivirus-induced immunomodulation. Adv. Virus Res. 2008, 71:173-205.
41. Kerdiles Y.M., Sellin C.I., Druelle J., Horvat B. Immunosuppression caused by measles virus: role of viral proteins. Rev. Med. Virol. 2006, 16:49-63.
42. Avota E., Muller N., Klett M., Schneider-Schaulies S. Measles virus interacts with and alters signal transduction in T-cell lipid rafts. J. Virol. 2004, 78:9552-9559.
43. Muller N., Avota E., Schneider-Schaulies J., Harms H., Krohne G., Schneider-Schaulies S. Measles virus contact with T cells impedes cytoskeletal remodeling associated with spreading, polarization, and CD3 clustering. Traffic 2006, 7:849-858.
44. Schneider-Schaulies J., Dunster L.M., Schwartz-Albiez R., Krohne G., ter Meulen V. Physical association of moesin and CD46 as a receptor complex for measles virus. J. Virol. 1995, 69:2248-2256.
45. Boulton I.C., Gray-Owen S.D. Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4+ T lymphocytes. Nat. Immunol. 2002, 3:229-236.
46. Merz A.J., So M. Attachment of piliated, Opa- and Opc- gonococci and meningococci to epithelial cells elicits cortical actin rearrangements and clustering of tyrosine-phosphorylated proteins. Infect. Immun. 1997, 65:4341-4349.
47. Lee S.W., Higashi D.L., Snyder A., Merz A.J., Potter L., So M. PilT is required for PI(3, 4, 5)P3-mediated crosstalk between Neisseria gonorrhoeae and epithelial cells. Cell. Microbiol. 2005, 7:1271-1284.
48. Kallstrom H., Liszewski M.K., Atkinson J.P., Jonsson A.B. Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. Mol. Microbiol. 1997, 25:639-647.
49. Weyand N.J., Lee S.W., Higashi D.L., Cawley D., Yoshihara P., So M. Monoclonal antibody detection of CD46 clustering beneath Neisseria gonorrhoeae microcolonies. Infect. Immun. 2006, 74:2428-2435.
50. Lue R.A., Brandin E., Chan E.P., Branton D. Two independent domains of hDlg are sufficient for subcellular targeting: the PDZ1-2 conformational unit and an alternatively spliced domain. J. Cell Biol. 1996, 135:1125-1137.
51. Price J.D., Schaumburg J., Sandin C., Atkinson J.P., Lindahl G., Kemper C. Induction of a regulatory phenotype in human CD4+ T cells by streptococcal M protein. J. Immunol. 2005, 175:677-684.
52. Dunkelberger J.R., Song W.C. Complement and its role in innate and adaptive immune responses. Cell Res. 2010, 20:34-50.
53. Kemper C., Atkinson J.P. T-cell regulation: with complements from innate immunity. Nat. Rev. Immunol. 2007, 7:9-18.
54. Liszewski M.K., Kemper C., Price J.D., Atkinson J.P. Emerging roles and new functions of CD46. Springer Semin. Immunopathol. 2005, 27:345-358.
55. Morgan B.P., Marchbank K.J., Longhi M.P., Harris C.L., Gallimore A.M. Complement: central to innate immunity and bridging to adaptive responses. Immunol. Lett. 2005, 97:171-179.
56. Russell S. CD46: a complement regulator and pathogen receptor that mediates links between innate and acquired immune function. Tissue Antigens 2004, 64:111-118.
57. Cua D.J., Groux H., Hinton D.R., Stohlman S.A., Coffman R.L. Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 1999, 189:1005-1010.
58. Astier A.L., Hafler D.A. Abnormal Tr1 differentiation in multiple sclerosis. J. Neuroimmunol. 2007, 191:70-78.
59. Astier A.L., Meiffren G., Freeman S., Hafler D.A. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J. Clin. Invest. 2006, 116:3252-3257.
60. Shusta E.V., Zhu C., Boado R.J., Pardridge W.M. Subtractive expression cloning reveals high expression of CD46 at the blood-brain barrier. J. Neuropathol. Exp. Neurol. 2002, 61:597-604.
61. Alvarez-Lafuente R., Garcia-Montojo M., De Las Heras V., Dominguez-Mozo M.I., Bartolome M., Arroyo R. CD46 expression and HHV-6 infection in patients with multiple sclerosis. Acta Neurol. Scand. 2009, 120:246-250.
62. Fishelson Z., Donin N., Zell S., Schultz S., Kirschfink M. Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors. Mol. Immunol. 2003, 40:109-123.
63. Fielding A.K. Measles as a potential oncolytic virus. Rev. Med. Virol. 2005, 15:135-142.
64. Barnard A.L., Igakura T., Tanaka Y., Taylor G.P., Bangham C.R. Engagement of specific T-cell surface molecules regulates cytoskeletal polarization in HTLV-1-infected lymphocytes. Blood 2005, 106:988-995.